nach oben

Erschienen in:

19.07.2016 | Nuclear Medicine

The added value of ⁶⁸Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin

verfasst von: Philipp M. Kazmierczak, Axel Rominger, Vera Wenter, Christine Spitzweg, Christoph Auernhammer, Martin K. Angele, Carsten Rist, Clemens C. Cyran

Erschienen in: European Radiology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To quantify the additional value of ⁶⁸Ga-DOTA-TATE PET/CT in comparison with contrast-enhanced CT alone for primary tumour detection in neuroendocrine cancer of unknown primary (CUP-NET).

Methods

In total, 38 consecutive patients (27 men, 11 women; mean age 62 years) with histologically proven CUP-NET who underwent a contrast-enhanced ⁶⁸Ga-DOTA-TATE PET/CT scan for primary tumour detection and staging between 2010 and 2014 were included in this IRB-approved retrospective study. Two blinded readers independently analysed the contrast-enhanced CT and ⁶⁸Ga-DOTA-TATE PET datasets separately and noted from which modality they suspected a primary tumour. Consensus was reached if the results were divergent. Postoperative histopathology (24 patients) and follow-up ⁶⁸Ga-DOTA-TATE PET/CT imaging (14 patients) served as the reference standards and statistical measures of diagnostic accuracy were calculated accordingly.

Results

The majority of confirmed primary tumours were located in the abdomen (ileum in 19 patients, pancreas in 12, lung in 2, small pelvis in 1). High interobserver agreement was noted regarding the suspected primary tumour site (Cohen’s k 0.90, p < 0.001). ⁶⁸Ga-DOTA-TATE PET demonstrated a significantly higher sensitivity (94 % vs. 63 %, p = 0.005) and a significantly higher accuracy (87 % vs. 68 %, p = 0.003) than contrast-enhanced CT.

Conclusions

Ga-DOTA-TATE PET/CT compared with contrast-enhanced CT alone provides an improvement in sensitivity of 50 % and an improvement in accuracy of 30 % in primary tumour detection in CUP-NET.

Key Points

• ⁶⁸Ga-DOTA-TATE PET augments the sensitivity of contrast-enhanced CT by 50 %

• ⁶⁸Ga-DOTA-TATE PET augments the accuracy of contrast-enhanced CT by 30 %

• Somatostatin receptor-targeted hybrid imaging optimizes primary tumour detection in CUP-NET

Pavlidis N, Pentheroudakis G (2012) Cancer of unknown primary site. Lancet 379:1428–1435CrossRefPubMed

Oien KA (2009) Pathologic evaluation of unknown primary cancer. Semin Oncol 36:8–37CrossRefPubMed

Massard C, Loriot Y, Fizazi K (2011) Carcinomas of an unknown primary origin – diagnosis and treatment. Nat Rev Clin Oncol 8:701–710CrossRefPubMed

Hemminki K, Bevier M, Hemminki A, Sundquist J (2012) Survival in cancer of unknown primary site: population-based analysis by site and histology. Ann Oncol 23:1854–1863CrossRefPubMed

Kazmierczak PM, Nikolaou K, Rominger A, Graser A, Reiser MF, Cyran CC (2014) Radiological diagnostics in CUP syndrome. Radiologe 54:117–123CrossRefPubMed

Moller AK, Loft A, Berthelsen AK et al (2012) A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site. Oncologist 17:1146–1154CrossRefPubMedPubMedCentral

Karsell PR, Sheedy PF 2nd, O'Connell MJ (1982) Computed tomography in search of cancer of unknown origin. JAMA 248:340–343CrossRefPubMed

Lee JR, Kim JS, Roh JL et al (2015) Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging – prospective study. Radiology 274:764–771CrossRefPubMed

Elboga U, Kervancioglu S, Sahin E, Basibuyuk M, Celen YZ, Aktolun C (2014) Utility of F-18 fluorodeoxyglucose positron emission tomography/computed in carcinoma of unknown primary. Int J Clin Exp Pathol 7:8941–8946PubMedPubMedCentral

10.

Han A, Xue J, Hu M, Zheng J, Wang X (2012) Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. Cancer Epidemiol 36:470–475CrossRefPubMed

11.

Pape UF, Perren A, Niederle B et al (2012) ENETS Consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology 95:135–156CrossRefPubMed

12.

Kayani I, Bomanji JB, Groves A et al (2008) Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer 112:2447–2455CrossRefPubMed

13.

Bergsland EK, Nakakura EK (2014) Neuroendocrine tumors of unknown primary: is the primary site really not known? JAMA Surg 149:889–890CrossRefPubMed

14.

Kjaer A, Knigge U (2015) Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors. Scand J Gastroenterol 50:740–747PubMedPubMedCentral

15.

Rossana B, Silvia R, Mariangela T et al (2016) Gastrointestinal neuroendocrine tumors: searching the optimal treatment strategy – a literature review. Crit Rev Oncol Hematol 98:264–274CrossRef

16.

Alonso O, Rodriguez-Taroco M, Savio E, Bentancourt C, Gambini JP, Engler H (2014) (68)Ga-DOTATATE PET/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin. Ann Nucl Med 28:638–645CrossRefPubMed

17.

Hofman MS, Lau WF, Hicks RJ (2015) Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics 35:500–516CrossRefPubMed

18.

Breeman WA, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP (2005) Radiolabelling DOTA-peptides with 68Ga. Eur J Nucl Med Mol Imaging 32:478–485CrossRefPubMed

19.

Naswa N, Sharma P, Kumar A et al (2012) (68)Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin. Clin Nucl Med 37:245–251CrossRefPubMed

20.

Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP (2010) Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. Eur J Nucl Med Mol Imaging 37:67–77CrossRefPubMed

21.

Ambrosini V, Nanni C, Zompatori M et al (2010) (68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 37:722–727CrossRefPubMed

22.

Auernhammer CJ, Goke B (2011) Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin. Gut 60:1009–1021CrossRefPubMed

23.

Ahmed A, Turner G, King B et al (2009) Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer 16:885–894CrossRefPubMed

24.

Hellman P, Lundstrom T, Ohrvall U et al (2002) Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg 26:991–997CrossRefPubMed

25.

Capurso G, Bettini R, Rinzivillo M, Boninsegna L, Delle Fave G, Falconi M (2011) Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review. Neuroendocrinology 93:223–229CrossRefPubMed

26.

Caplin ME, Baudin E, Ferolla P et al (2015) Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol 26:1604–1620CrossRefPubMed

27.

Johnbeck CB, Knigge U, Kjaer A (2014) PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature. Future Oncol 10:2259–2277CrossRefPubMed

28.

Kabasakal L, Demirci E, Ocak M et al (2012) Comparison of (68)Ga-DOTATATE and (68)Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 39:1271–1277CrossRefPubMed

29.

Kwee TC, van Ufford HM, Beek FJ et al (2009) Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Invest Radiol 44:683–690CrossRefPubMed

30.

Look Hong NJ, Petrella T, Chan K (2015) Cost-effectiveness analysis of staging strategies in patients with regionally metastatic melanoma. J Surg Oncol 111:423–430CrossRefPubMed

31.

Baur AD, Pavel M, Prasad V, Denecke T (2016) Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment. Acta Radiol 57:260–270CrossRefPubMed

32.

Ruf J, Schiefer J, Furth C et al (2011) 68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol. J Nucl Med 52:697–704CrossRefPubMed

33.

Manfredi R, Bonatti M, Mantovani W et al (2013) Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour. Eur Radiol 23:3029–3039CrossRefPubMed

Titel: The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin
verfasst von: Philipp M. Kazmierczak
Axel Rominger
Vera Wenter
Christine Spitzweg
Christoph Auernhammer
Martin K. Angele
Carsten Rist
Clemens C. Cyran
Publikationsdatum: 19.07.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 4/2017
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-016-4475-3

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The added value of ⁶⁸Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Prediction of presence of kidney disease in patients undergoing intravenous iodinated contrast enhanced computed tomography: a validation study

Compression of the superior mesenteric vein—a sign of acute internal herniation in patients with antecolic laparoscopic Roux-en-Y gastric bypass

Percutaneous vertebroplasty under local anaesthesia: feasibility regarding patients’ experience

Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign

Lung perfusion characteristics in pulmonary arterial hypertension (PAH) and peripheral forms of chronic thromboembolic pulmonary hypertension (pCTEPH): Dual-energy CT experience in 31 patients

Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie